Dare Bioscience, Inc. Line of Credit Facility, Maximum Borrowing Capacity
Dare Bioscience, Inc. (DARE) had Line of Credit Facility, Maximum Borrowing Capacity of $2.00 million as of 2017-06-30, per its 8-K/A filed 2017-10-02.
Discontinued › Notes › Debt
us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity · last filed 2017-10-02
- 2017-06-30: Line of Credit Facility, Maximum Borrowing Capacity $2.00M.
- 2016-04-02: Line of Credit Facility, Maximum Borrowing Capacity $1.00M.
| Period end | Line of Credit Facility, Maximum Borrowing Capacity |
|---|---|
| 2017-06-30 | $2.00M 8-K/A · filed 2017-10-02 |
| 2016-04-02 | $1.00M 8-K/A · filed 2017-10-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |